{
    "q&r": [
        {
            "question":"According to the clinical context, which tests mentioned in the following list are relevant?",
            "statement": "Mrs. T. 60-years old suffers from multiple myeloma diagnosed 3 years ago.\nSince 1 month, she is experiencing repeated mucocutaneous bleeding (epistaxis). She indicates that she is not under anticoagulant treatment. A coagulation workup is requested.",
            "information":"",
            "multiple_choises":true,
            "responses":[
                {
                    "reponse":"Prothrombin time",
                    "correct":true
                },
                {
                    "reponse":"Bleeding time",
                    "correct":false
                },
                {
                    "reponse":"aPTT",
                    "correct":true
                },
                {
                    "reponse":"Fibrinogen assay",
                    "correct":true
                }
            ],
            "explanation":"<html><body style=\"font-family: helvetica, verdana, sans-serif;font-size:13px; margin-left:0px;\">The first line coagulation workup for bleeding disorders is based on two routine global assays which check the global coagulation process: prothrombin time (PT) and activated partial thromboplastin time (aPTT). As a reminder, PT is sensitive to Factor II, V, VII and X defects and fibrinogen when significantly decreased, whereas aPTT is sensitive to all unless Factor VII defects, and is primarily used for detection of intrinsic pathway factors defects, i.e. Factor VIII, IX, XI and XII.<br><br>Fibrinogen assay is used to explore dysfibrinogenemia, hypofibrinogenemia or afibrinogenemia. PT or aPTT sensitivity may be inadequate to detect this kind of defects possibly associated with bleeding manifestations. This assay can therefore be useful for this patient.<br><br>In the past, the bleeding time (BT) was performed as part of presurgery screening as well as for a bleeding disorder exploration. BT shows poor reproducibility, sensitivity and specificity as well as poor predictive value. Furthermore, BT is an invasive procedure that may result in useless inconvenience and scares. As a conclusion, BT is not a relevant test in this context.</body></html>"
        },
        {
            "question":"According to these results, which additional testing would you perform?",
            "statement": "LABORATORY RESULTS\nRoutine test results are as follows:\n\nPT (STA® Neoplastin® CI Plus):\n    -    13.5 s (control 12.9 s)\n    -    96%\n    -    PT ratio : 1.05\n\nAPTT (STA® PTT Automate®)\n    -    62 s (control : 32 s)\n    -    aPTT ratio : 1.94\n\nFibrinogen (STA® Fibrinogen): 2.76 g/L",
            "information":"",
            "multiple_choises":true,
            "responses":[
                {
                    "reponse":"Mixing study",
                    "correct":true
                },
                {
                    "reponse":"Intrinsic pathway factor assays",
                    "correct":false
                },
                {
                    "reponse":"Extrinsic pathway factor assays",
                    "correct":true
                },
                {
                    "reponse":"D-dimer assay",
                    "correct":true
                }
            ],
            "explanation":"<html><body style=\"font-family: helvetica, verdana, sans-serif;font-size:13px; margin-left:0px;\">In case of prolonged aPTT, it is recommended to perform mixing study, this simple procedure allows diagnosis guidance towards either factor deficiency (if corrected) or circulating anticoagulant (if not corrected).<br><br>Endogenous factor defect may be associated with aPTT prolongation. In this context, endogenous pathway factor assay is recommended. Only factors VIII, IX or XI defects are associated with bleeding risk. A Factor XII defect, although not associated with a bleeding tendency, may be performed in order to explain isolated aPTT prolongation. <br><br>The extrinsic pathway factor assays are indicated for the exploration of a prolonged PT, in order to identify an isolated or combined defect of Factor II, V, VII and X. In this case of a normal PT, such assays are not indicated. <br><br>D-dimer is a marker of fibrin degradation. The quantification of D-dimer plasma level is indicated in several indications including the exclusion of deep venous thromboembolism and the diagnosis and follow-up of disseminated intravascular coagulation. In this context of bleeding manifestations, this assay is not relevant.</body></html>"
        },
        {
            "question":"According to the laboratory test results, which haemostasis specialized test(s) would you choose to perform?",
            "statement": "LABORATORY RESULTS\nAPTT mixing study (STA® PTT Automate®)\n    -    Patient: 65 s (control : 32 s)\n    -    Patient + pooled normal plasma (1/1): 36 s\n    -    ICA: 6%\n\nIntrinsic pathway\nFVIII: 7%\nFIX: 94%\nFXI: 104%\nFXII: 87%",
            "information":"",
            "multiple_choises":true,
            "responses":[
                {
                    "reponse":"Anti-Xa activity measurement",
                    "correct":false
                },
                {
                    "reponse":"Von Willebrand factor antigen (VWF:Ag)",
                    "correct":true
                },
                {
                    "reponse":"Von Willebrand factor ristocetin cofactor activity (VWF:RCo) ",
                    "correct":true
                },
                {
                    "reponse":"Antiphospholipid antibodies screening",
                    "correct":false
                }
            ],
            "explanation":"<html><body style=\"font-family: helvetica, verdana, sans-serif;font-size:13px; margin-left:0px;\">The goal of additional testing is to differentiate between isolated factor VIII defect (inherited or acquired haemophilia A) and von Willebrand disease (VWD)(either inherited or acquired). VWD diagnosis is primarily based on the measurement of von Willebrand factor antigen (VWF:Ag) and the measurement of von Willebrand factor ristocetin cofactor activity (VWF:RCo).<br><br>Most VWD variants can be identified with this two assays. <br><br>Further characterization of VWD is based on the use of more specialized assays such as: VWF collagen binding (VWF:CB), VWF Factor VIII binding (VWF:FVIIIB) and multimer analysis. <br><br>VWF acts as a carrier protein for FVIII, protecting it from degradation and extending its plasma half-life. FVIII may be variably decreased in most of VWD types. <br><br>Screening for antiphospholipid antibodies is indicated for the antiphospholipid syndrome diagnosis, which is mainly associated with thrombotic events. In this case of isolated FVIII deficiency, antiphospholipid antibodies screening is not relevant. <br><br>Anti-Xa activity is dedicated for the assessment of anti-Xa drug anticoagulant activity (heparins, fondaparinux, rivaroxaban, apixaban, edoxaban) and is not relevant out of this kind of treatment.</body></html>"
        },
        {
            "question":"According to the physiopathological context and the lab tests results, what is the most likely diagnosis?",
            "statement": "Specialized assays results are as follow. Furthermore, the patient’s interview do not reveal family nor personal history of bleedings.\nLABORATORY RESULTS\nSpecialized test results are as follows:\n\nVWF:Ag (STA®-Liatest® VWF:Ag): 12 %\n    -    Normal ranges: 50-150 %n    VWF:RCo (ABP VWF Ricof Assay): 9 %n    -    Normal ranges: 50-150 %",
            "information":"",
            "multiple_choises":false,
            "responses":[
                {
                    "reponse":"Inherited von Willebrand disease",
                    "correct":false
                },
                {
                    "reponse":"Acquired von Willebrand disease",
                    "correct":true
                },
                {
                    "reponse":"Acquired Haemophilia A",
                    "correct":false
                },
                {
                    "reponse":"Heparin Induced Thrombocytopenia",
                    "correct":false
                }
            ],
            "explanation":"<html><body style=\"font-family: helvetica, verdana, sans-serif;font-size:13px; margin-left:0px;\">Inherited FVIII defect or inherited VWD is unlikely due to the lack of personal or familial bleeding history. The most likely diagnosis is acquired VWD. This diagnosis is supported by the concomitant multiple myeloma; indeed acquired VWD is most often associated with lymphoma, multiple myeloma, Waldenström disease and autoimmune diseases.<br><br>Acquired haemophilia A diagnosis can be ruled out as low FVIII level is due to VWF deficiency.<br><br>Heparin-induced thrombocytopenia (HIT) is a complication of heparin treatment, which is not the context for this patient.</body></html>"
        },
        {
            "question":"Among the following statements, which one(s) is (are) correct?",
            "statement": "",
            "information":"",
            "multiple_choises":true,
            "responses":[
                {
                    "reponse":"Von Willebrand factor antigen assay is sufficient for the von Willebrand disease diagnosis",
                    "correct":false
                },
                {
                    "reponse":"Desmopressin is effective for treating certain types of von Willebrand disease",
                    "correct":true
                },
                {
                    "reponse":"Increase of von Willebrand factor may be observed during inflammatory syndromes",
                    "correct":true
                },
                {
                    "reponse":"The von Willebrand disease has been discovered in the twentieth century in a population from one south Pacific island",
                    "correct":false
                }
            ],
            "explanation":"<html><body style=\"font-family: helvetica, verdana, sans-serif;font-size:13px; margin-left:0px;\">VWD is multifaceted. VWD classification is based on laboratory assay test panel results (Cf Table I). VWF:Ag result is not sufficient to allow adequate VWD typing.<br><br><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 style='border-collapse:collapse;mso-table-layout-alt:fixed;border:none; mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:1184;mso-padding-alt: 0cm 5.4pt 0cm 5.4pt;mso-border-insideh:.5pt solid windowtext;mso-border-insidev: .5pt solid windowtext'> <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'> <td width=89 rowspan=2 valign=top style='width:88.95pt;border:solid windowtext 1.0pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span lang=EN-US style='font-size:9.0pt;line-height:107%;font-family:Arial;mso-ansi-language: EN-US'><o:p>&nbsp;</o:p></span></b></p></td><td width=67 rowspan=2 valign=bottom style='width:66.75pt;border:solid windowtext 1.0pt; border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:normal'><span style='font-size:9.0pt;line-height: 107%;font-family:Arial'>VWD type 1<o:p></o:p></span></b></p></td><td width=217 colspan=4 style='width:216.5pt;border:solid windowtext 1.0pt; border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:normal'><span style='font-size:9.0pt;line-height: 107%;font-family:Arial'>VWD type 2<o:p></o:p></span></b></p></td><td width=67 rowspan=2 valign=bottom style='width:67.0pt;border:solid windowtext 1.0pt; border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:normal'><span style='font-size:9.0pt;line-height: 107%;font-family:Arial'>VWD type 3<o:p></o:p></span></b></p></td></tr><tr style='mso-yfti-irow:1'> <td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:normal'><span style='font-size:9.0pt;line-height: 107%;font-family:Arial'>2A<o:p></o:p></span></b></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:normal'><span style='font-size:9.0pt;line-height: 107%;font-family:Arial'>2B<o:p></o:p></span></b></p></td><td width=46 style='width:46.45pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:normal'><span style='font-size:9.0pt;line-height: 107%;font-family:Arial'>2M<o:p></o:p></span></b></p></td><td width=57 style='width:56.65pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><b style='mso-bidi-font-weight:normal'><span style='font-size:9.0pt;line-height: 107%;font-family:Arial'>2N<o:p></o:p></span></b></p></td></tr><tr style='mso-yfti-irow:2'> <td width=439 colspan=7 style='width:439.2pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>Initial tests<o:p></o:p></span></b></p></td></tr><tr style='mso-yfti-irow:3'> <td width=89 valign=top style='width:88.95pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span style='font-size:9.0pt;line-height:107%;font-family: Arial'>FVIII:C<o:p></o:p></span></p></td><td width=67 style='width:66.75pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>N or ↓<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>N or ↓<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>N or ↓<o:p></o:p></span></p></td><td width=46 style='width:46.45pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>N<o:p></o:p></span></p></td><td width=57 style='width:56.65pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>↓↓<o:p></o:p></span></p></td><td width=67 style='width:67.0pt;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>↓↓↓<o:p></o:p></span></p></td></tr><tr style='mso-yfti-irow:4'> <td width=89 valign=top style='width:88.95pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span class=SpellE><span style='font-size:9.0pt; line-height:107%;font-family:Arial'>VWF:Ag</span></span><span style='font-size:9.0pt;line-height:107%;font-family:Arial'><o:p></o:p></span></p></td><td width=67 style='width:66.75pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>B or ↓ or ↓↓<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>B or ↓ or ↓↓<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span style='font-size:9.0pt;line-height:107%;font-family: Arial'>B or ↓<o:p></o:p></span></p></td><td width=46 style='width:46.45pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span style='font-size:9.0pt;line-height:107%;font-family: Arial'>B or ↓ or ↓↓<o:p></o:p></span></p></td><td width=57 style='width:56.65pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>N or B<o:p></o:p></span></p></td><td width=67 style='width:67.0pt;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>↓↓↓<o:p></o:p></span></p></td></tr><tr style='mso-yfti-irow:5'> <td width=89 valign=top style='width:88.95pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span class=SpellE><span style='font-size:9.0pt; line-height:107%;font-family:Arial'>VWF:RCo</span></span><span style='font-size:9.0pt;line-height:107%;font-family:Arial'><o:p></o:p></span></p></td><td width=67 style='width:66.75pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>B or ↓ or ↓↓<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>↓ or ↓↓ or ↓↓↓<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>↓↓<o:p></o:p></span></p></td><td width=46 style='width:46.45pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>↓ or ↓↓ or ↓↓↓<o:p></o:p></span></p></td><td width=57 style='width:56.65pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>N or B<o:p></o:p></span></p></td><td width=67 style='width:67.0pt;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>↓↓↓<o:p></o:p></span></p></td></tr><tr style='mso-yfti-irow:6'> <td width=89 valign=top style='width:88.95pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span class=SpellE><span lang=EN-US style='font-size:9.0pt; line-height:107%;font-family:Arial;mso-ansi-language:EN-US'>VWF:RCo</span></span><span lang=EN-US style='font-size:9.0pt;line-height:107%;font-family:Arial; mso-ansi-language:EN-US'>/ <span class=SpellE>VWF:Ag</span> ratio<o:p></o:p></span></p></td><td width=67 style='width:66.75pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>&gt; 0,5 Ð 0,7<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>&lt; 0,5 Ð 0,7<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>&lt; 0,5 Ð 0,7<o:p></o:p></span></p></td><td width=46 style='width:46.45pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>&lt; 0,5 Ð 0,7<o:p></o:p></span></p></td><td width=57 style='width:56.65pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>&gt; 0,5 Ð 0,7<o:p></o:p></span></p></td><td width=67 style='width:67.0pt;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>NA<o:p></o:p></span></p></td></tr><tr style='mso-yfti-irow:7'> <td width=439 colspan=7 style='width:439.2pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span class=SpellE><b style='mso-bidi-font-weight:normal'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>Supplemental</span></b></span><b style='mso-bidi-font-weight:normal'><span style='font-size:9.0pt;line-height: 107%;font-family:Arial'> tests<o:p></o:p></span></b></p></td></tr><tr style='mso-yfti-irow:8'> <td width=89 valign=top style='width:88.95pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span style='font-size:9.0pt;line-height:107%;font-family: Arial'>VWF:CB<o:p></o:p></span></p></td><td width=67 style='width:66.75pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>N or B or ↓ or ↓↓<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>↓↓↓<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>↓ or ↓↓<o:p></o:p></span></p></td><td width=46 style='width:46.45pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>N or B<o:p></o:p></span></p></td><td width=57 style='width:56.65pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>N<o:p></o:p></span></p></td><td width=67 style='width:67.0pt;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>↓↓↓<o:p></o:p></span></p></td></tr><tr style='mso-yfti-irow:9'> <td width=89 valign=top style='width:88.95pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span lang=EN-US style='font-size:9.0pt;line-height:107%; font-family:Arial;mso-ansi-language:EN-US'>VWF:CB/ <span class=SpellE>VWF:Ag</span> ratio<o:p></o:p></span></p></td><td width=67 style='width:66.75pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>&gt; 0,5 Ð 0,7<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>&lt; 0,5 Ð 0,7<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>&lt; 0,5 Ð 0,7<o:p></o:p></span></p></td><td width=46 style='width:46.45pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>&gt; 0,5 Ð 0,7<o:p></o:p></span></p></td><td width=57 style='width:56.65pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>&gt; 0,5 Ð 0,7<o:p></o:p></span></p></td><td width=67 style='width:67.0pt;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>NA<o:p></o:p></span></p></td></tr><tr style='mso-yfti-irow:10;mso-yfti-lastrow:yes'> <td width=89 valign=top style='width:88.95pt;border:solid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal><span style='font-size:9.0pt;line-height:107%;font-family: Arial'>VWF:FVIIIB<o:p></o:p></span></p></td><td width=67 style='width:66.75pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>N<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>N<o:p></o:p></span></p></td><td width=57 style='width:2.0cm;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>N<o:p></o:p></span></p></td><td width=46 style='width:46.45pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>N<o:p></o:p></span></p></td><td width=57 style='width:56.65pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>↓↓↓<o:p></o:p></span></p></td><td width=67 style='width:67.0pt;border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;mso-border-top-alt: solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;mso-border-alt: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;line-height:107%;font-family:Arial'>Absent<o:p></o:p></span></p></td></tr></table><b>Table I: VWD Laboratory diagnosis</b><br><span style=\"font-size:12px;\">VWD : von Willebrand disease, FVIII:C : Factor VIII activity, VWF:Ag : von  Willebrand factor antigen, VWF:RCo : von Wilebrand factor ristocetin cofactor actcivity, VWF:CB : von Willebrand factor collagen binding capacity, VWF:FVIIIB : von Willebrand factor factor VIII binding capacity, N : normal, B : borderline, NA : not applicable</span><br><br>Desmopressin (DDAVP), a synthetic analogue of natural pituitary hormone ADH, is a common therapy for VWD because it causes temporary release of endogenous stores of VWF and FVIII from Weibel-Palade bodies of endothelial cells. Desmopressin is effective for treating only certain types of VWD, usually type 1, but also some cases of type 2 (controversial for type 2B). This form of therapy is generally ineffective in type 3 VWD.Before desmopressin is administrated therapeutically, response to desmopressin should be determined for each patient.<br><br>VWF is an acute phase protein, as well as FVIII. Thus, VWF and FVIII levels are increased during inflammation. It is recommended to measure both VWF and FVIII apart from any acute phase in order to avoid misdiagnosis.<br><br>Erik von Willebrand, a Finnish physician, was the first to extensively study the disease in the Åland Islands located in Baltic Sea. He reported “hereditary pseudo-haemophilia” patient cases, members of a unique family, in which one third experienced bleeding events, affecting equally males and females in contrast to haemophilia. The term von Willebrand disease appeared in the late 1930’s.<br><br><br>References:<br><ul><li>Laffan MA, Lester W, O'Donnell JS et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Brit J Haematol 2014; 167: 453-5.</li><li>NCCLS. Assays of von Willebrand Factor Antigen and Ristocetin Cofactor Activity; Approved Guideline. NCCLS document H51-A. NCCLS, 940 West Valley Road, Suite 1400, Wayne. Pennsylvania 19087-1898 USA. 2002.</li><li>Castaman G, Goodeve A, Eikenboom J. Principles of care for the diagnosis and treatment of von Willebrand disease. Haematologica 2013; 98: 667-74.</li></ul></body></html>"
        }
    ]
}

